A

Amphista Therapeutics Limited

64 employees

Amphista Therapeutics operates as a biopharmaceutical company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Chemistry
Targeted Protein Degradation
Development
Biology
Biopharma
Drug Discovery

Date founded

2017

Funding rounds raised

Total raised

$53M

from 7 investors over 7 rounds

A

Amphista Therapeutics Limited raised undisclosed on December 13, 2022

Investors: The Dementia Discovery Fund

A

Amphista Therapeutics Limited raised $53M on March 17, 2021

Investors: BioMotiv, Forbion, Advent Life Sciences and Gilde Healthcare

A

Amphista Therapeutics Limited raised $7.5M on April 7, 2020

Investors: BioMotiv and Advent Life Sciences

FAQ